Yahoo
OTC Markets OTCPK - Delayed Quote USD

THC Biomed Intl Ltd. (THCBF)

0.0010 0.0000 (0.00%)
At close: November 4 at 4:00:00 PM EST
Chart Range Bar
Loading chart for THCBF
  • Previous Close 0.0010
  • Open 0.0245
  • Bid 0.0098 x --
  • Ask 0.0245 x --
  • Day's Range 0.0245 - 0.0245
  • 52 Week Range 0.0010 - 0.0245
  • Volume 394
  • Avg. Volume 0
  • Market Cap (intraday) 163,938
  • Beta (5Y Monthly) -167.75
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0200
  • Earnings Date --
  • Forward Dividend & Yield -- (0.00%)
  • Ex-Dividend Date --
  • 1y Target Est --

THC Biomed Intl Ltd. engages in the research, development, production, and sale of cannabis products in Canada. The company offers cannabis consumables, including beverage drinks, gummies, baked goods, pre-rolls, sticks, and clones under the THC Kiss brand name; and genetic strains under the THC BioMed brand name. It also provides dry flowers under the Smoke That Thunders brand name; buds under the Always Hi brand name; and transport solution for young live plants under the Cloneshipper brand name. The company was founded in 2012 and is based in Kelowna, Canada.

thcbiomed.com

35

Full Time Employees

July 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 11/5/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

THCBF
0.00%
S&P 500 (^GSPC)
7.42%

1-Year Return

THCBF
0.00%
S&P 500 (^GSPC)
8.20%

3-Year Return

THCBF
95.49%
S&P 500 (^GSPC)
68.73%

5-Year Return

THCBF
98.68%
S&P 500 (^GSPC)
56.54%

Earnings Trends

View More

Earnings Per Share

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q3 FY21
Revenue 1.11M
Earnings -1.32M
Profit Margin -118.93%

Q3

FY21

-1M
-500K
0
500K
1M
-118.9%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -164.79%

  • Return on Assets (ttm)

    -15.27%

  • Return on Equity (ttm)

    -56.47%

  • Revenue (ttm)

    2.23M

  • Net Income Avi to Common (ttm)

    -3.67M

  • Diluted EPS (ttm)

    -0.0200

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    205.01k

  • Total Debt/Equity (mrq)

    102.25%

  • Levered Free Cash Flow (ttm)

    1.07M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: